Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

安维乐 - NMPA Drug Approval Details

Approvals/NMPA/Irbesartan and Hydrochlorothiazide Capsules

Approved

化学药品

Irbesartan and Hydrochlorothiazide Capsules

北京四环科宝制药股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Dec 23, 2022
Approval ID: 7LeaeH0p8TJ
Company: 北京四环科宝制药股份有限公司
Type: 化学药品

Approval Details

Approval Id: 7LeaeH0p8TJ
Approval Number: 国药准字H20130002
Generic Name: 厄贝沙坦氢氯噻嗪胶囊
Generic Name En: Irbesartan and Hydrochlorothiazide Capsules
Brand Name: 安维乐
Drug Type: 化学药品
Dosage Form: 胶囊剂
Strength: 每粒含厄贝沙坦150mg，氢氯噻嗪12.5mg
Reg Date: 2022-12-23
Company Name: 北京四环科宝制药股份有限公司
Company Address: 北京市丰台区科技园区海鹰路11号[园区]
Production Company Name: 北京四环科宝制药股份有限公司
Production Company Address: 北京市大兴区中关村科技园区大兴生物医药基地祥瑞街5号
Company Detail Path: /organization/a2bb13eadc8c80dd/bei-jing-si-huan-ke-bao-zhi-yao-gu-fen-you-xian-gong-si
Production Company Detail Path: /organization/a2bb13eadc8c80dd/bei-jing-si-huan-ke-bao-zhi-yao-gu-fen-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 23, 2022

Approval ID

7LeaeH0p8TJ

Type

化学药品

Back to NMPA Approvals